Citations 1
Docetaxel-Induced Stevens-Johnson Syndrome in a Patient with Metastatic Prostate Adenocarcinoma
Diab, Osama , McEntire, Dan, Kassim, Thamer , Nayfeh, Ali , Dajani, Abdel, Kerfeld, Mitchell J. , Campbell, Jonathon, Alsuwaidan, Adbullah, Hazeem, Mahmoud Abu , Gbadamosi-Akindele, Maryam
Case Reports in Oncological Medicine | January 8, 2019 | Volume: 2019 | Issue: No issue available | Pages: 1-4
Docetaxel is a commonly used chemotherapeutic agent in a variety of cancer treatment regimens. We present a case of apparent docetaxel-induced Stevens-Johnson syndrome (SJS) in a patient recently treated for metastatic prostate cancer. This medication is not classically associated with the development of SJS but in our case, along with a number of other case reports, and a single phase II clinical trial, an association was recognized. We encourage clinicians who employ the use of this medication to be aware of this relationship.